Adaptive Deep Brain Stimulation for Parkinson's Disease: Navigating the Roadblocks to Clinical Implementation

Area of Science:

• Neuroscience
• Biomedical Engineering
• Neurology

Background:

• Conventional deep brain stimulation (cDBS) is a standard treatment for Parkinson's disease (PD).
• Adaptive deep brain stimulation (aDBS) enhances cDBS by using real-time physiological signals to adjust stimulation.
• This dynamic approach aims for more precise symptom modulation and improved device efficiency.

Purpose of the Study:

• To review the current state and future directions of adaptive deep brain stimulation (aDBS) for Parkinson's disease.
• To identify opportunities and challenges in the clinical implementation of aDBS.
• To discuss the potential of aDBS to refine Parkinson's disease treatment.

Main Methods:

• Review of current literature and clinical experience with aDBS in Parkinson's disease.
• Analysis of technical challenges, including biomarker variability and signal processing.
• Discussion of factors influencing clinical adoption, such as patient selection and ethical considerations.

Main Results:

• aDBS shows potential for more precise motor symptom control and reduced side effects compared to cDBS.
• Key challenges include inter-individual variability, programming diversity, and signal artifact management.
• Wearable sensors and patient-reported outcomes are emerging as important multimodal biomarkers.

Conclusions:

• aDBS is transitioning from experimental to clinical reality, supported by growing evidence and regulatory approvals.
• Further development of robust control strategies and scalable clinical workflows is crucial.
• Balancing automation with individualized patient care is essential for successful aDBS implementation in Parkinson's disease.